Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 46: 1239-1251, 2000;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baynes, R. D.
Right arrow Articles by Peters, W. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baynes, R. D.
Right arrow Articles by Peters, W. P.
Related Collections
Right arrow Arnold O. Beckman Conference
Right arrow Hematology
(Clinical Chemistry. 2000;46:1239-1251.)
© 2000 American Association for Clinical Chemistry, Inc.

Articles

Bone Marrow and Peripheral Blood Hematopoietic Stem Cell Transplantation: Focus on Autografting

Roy D. Baynesa,1, Caroline Hamm1, Roger Dansey1, Jared Klein1, Lucinda Cassells1, Chatchada Karanes1, Esteban Abella1 and William P. Peters1

1 Bone Marrow Transplant Program, Barbara Ann Karmanos Cancer Institute at Wayne State University, 3990 John R, 4 Brush South, Detroit, MI 48201.
a Author for correspondence. Fax 313-966-7656; e-mail baynesr{at}karmanos.org

This review focuses on certain of the principles involved in high-dose chemotherapy and radiation therapy along with autologous hematopoietic stem cell transplantation for the treatment of certain malignancies. In addition, the evidence, wherever possible based on randomized data, for the application of this approach in certain malignancies is reviewed. The malignancies highlighted include acute myeloid leukemia, acute lymphoblastic leukemia, non-Hodgkin lymphoma, Hodgkin disease, and breast cancer.




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
S. D. Narasipura, J. C. Wojciechowski, N. Charles, J. L. Liesveld, and M. R. King
P-Selectin Coated Microtube for Enrichment of CD34+ Hematopoietic Stem and Progenitor Cells from Human Bone Marrow
Clin. Chem., January 1, 2008; 54(1): 77 - 85.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Association for Clinical Chemistry.